Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02671448 · ClinicalTrials.gov registry record · NA
Pilot Trial of Homebound Stem Cell Transplantation
A NA study of Plasma Cell Dyscrasia, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 91
- Enrollment target
- 1
- Study location
NCT02671448 is a NA study of Plasma Cell Dyscrasia that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 91 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02671448, a NA study of Plasma Cell Dyscrasia, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 91 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study, the investigators plan to see what happens when a person receives care in the home setting. They want to find out if caring for a patient who has been treated with an ASCT in the home setting is feasible. They want to find out what effects good and/or bad this will have on the patient's recovery and treatment after ASCT. Studies in other institutions have shown that providing care in the home setting after ASCT is safe, increases patient satisfaction, and can decrease the risk of infection. It is our hope that this new approach of providing care in the home setting will prove to be a feasible and safe option for patients at Memorial Sloan Kettering Cancer Center (MSK).
Conditions Studied
Interventions
- BEHAVIORAL Home monitoring teleconsult visits
- BEHAVIORAL Patient Reported Outcomes (PRO)
- BEHAVIORAL Caregiver Reported Outcomes instruments
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2016-01 |
| Est. Completion | 2027-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02671448
The ClinicalTrials.gov registry entry for NCT02671448 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Plasma Cell Dyscrasia appearing as the primary indexed condition, and to 3 interventions - of which Home monitoring teleconsult visits is the first listed.
NCT02671448 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02671448 about?
NCT02671448 is a clinical study titled "Pilot Trial of Homebound Stem Cell Transplantation". In this study, the investigators plan to see what happens when a person receives care in the home setting. They want to find out if caring for a patient who has been treated with an ASCT in the home setting is feasible. They want to find out what effects good and/or bad this will have on the patient...
What is the current status of trial NCT02671448?
This trial is currently recruiting. It is a NA study. The enrollment target is 91 participants. The study started on 2016-01. Estimated completion is 2027-01.
What conditions does trial NCT02671448 study?
This clinical trial studies the following conditions: Plasma Cell Dyscrasia.
What interventions are being tested in trial NCT02671448?
The interventions under investigation include: Home monitoring teleconsult visits (BEHAVIORAL), Patient Reported Outcomes (PRO) (BEHAVIORAL), Caregiver Reported Outcomes instruments (BEHAVIORAL).
Who is sponsoring clinical trial NCT02671448?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02671448 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Plasma Cell Dyscrasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.